Trademark: 97047610
Status Date
Monday, April 1, 2024
Filing Date
Monday, September 27, 2021
Published for Opposition
Tuesday, September 6, 2022
9 Downloadable computer software for the treatment of major depressive disorder and other mental health disorders, namely, software for collecting biometric data from patients and delivering a cognitive emotional neurobehavioral treatment; Software as a Medical Device (SaMD), downloadable, for the treatment of major depressive disorder and other mental health disorders, namely, software for collecting biometric data from patients and delivering a cognitive emotional neurobehavioral treatment
44 Medical services, and providing information and advice relating thereto; mental health therapy service, and providing information and advice relating thereto; providing medical information; behavioral health services in the nature of outpatient treatment and medication monitoring, and providing information and advice relating thereto; medical counselling in the nature of counseling in the field of mental health and wellness, and providing information and advice relating thereto; rehabilitation patient care services, namely, rehabilitation of patients with mental diseases, and providing information and advice relating thereto; psychotherapy, and providing information and advice relating thereto; cognitive therapy services, and providing information and advice relating thereto
42 Providing temporary use of online non-downloadable software for the treatment of major depressive disorder and other mental health disorders, namely, software for collecting biometric data from patients and delivering a cognitive emotional neurobehavioral treatment; platform as a service (PaaS) featuring computer software platforms for the treatment of major depressive disorder and other mental health disorders, namely, software for collecting biometric data from patients and delivering a cognitive emotional neurobehavioral treatment; software as a service (SaaS) for the treatment of major depressive disorder and other mental health disorders, namely, software for collecting biometric data from patients and delivering a cognitive emotional neurobehavioral treatment
Apr 2, 2024
Notice Of Approval Of Extension Request E-Mailed
Apr 1, 2024
Sou Extension 3 Granted
Apr 1, 2024
Sou Extension 3 Filed
Apr 1, 2024
Sou Teas Extension Received
Dec 5, 2023
Assigned To Examiner
Sep 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 19, 2023
Sou Extension 2 Granted
Sep 19, 2023
Sou Extension 2 Filed
Sep 19, 2023
Sou Teas Extension Received
Apr 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 26, 2023
Sou Extension 1 Granted
Apr 26, 2023
Sou Extension 1 Filed
Apr 26, 2023
Sou Teas Extension Received
Nov 1, 2022
Noa E-Mailed - Sou Required From Applicant
Sep 6, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 6, 2022
Published For Opposition
Aug 17, 2022
Notification Of Notice Of Publication E-Mailed
Aug 1, 2022
Approved For Pub - Principal Register
Jul 29, 2022
Teas/Email Correspondence Entered
Jul 29, 2022
Correspondence Received In Law Office
Jul 29, 2022
Teas Response To Office Action Received
Jul 29, 2022
Teas Response To Office Action Received
Jul 14, 2022
Notification Of Non-Final Action E-Mailed
Jul 14, 2022
Non-Final Action E-Mailed
Jul 14, 2022
Non-Final Action Written
Jul 1, 2022
Assigned To Examiner
Jun 27, 2022
Assigned To Examiner
Nov 8, 2021
Preliminary/Voluntary Amendment - Entered
Nov 4, 2021
Assigned To Lie
Oct 13, 2021
Teas Voluntary Amendment Received
Oct 27, 2021
New Application Office Supplied Data Entered
Sep 30, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
